Mortality in severe, non aggressively treated adult autoimmune thrombocytopenia

Hematology Journal

Volumn 4, Issue 5, 2003, Pages 366-369

  Sailer, Thomas ^a   Weltermann, Ansgar ^a   Zoghlami, Claudia ^a   Kyrle, Paul Alexander ^a   Lechner, Klaus ^a   Pabinger, Ingrid ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Autoimmune thrombocytopenia; Mortality; Platelets; Survival; Treatment

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOGLOBULIN; PREDNISOLONE; PREDNISONE;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BLEEDING; CAUSE OF DEATH; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; SIDE EFFECT; SPLENECTOMY; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; HEMORRHAGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED; MORTALITY; PLATELET COUNT; PREDNISOLONE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RETROSPECTIVE STUDIES; SPLENECTOMY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0141960101     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200299     Document Type: Article

References (21)

1. Gillis S, Eldor A. Immune thrombocytopenic purpura in adults: clinical aspects. Baillieres Clin Haematol 1998; 2: 361-372.
2. Lechner K. Management of adult thrombocytopenia. Clin Exp Hematol 2001; 5: 222-235.
3. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 1997; 349: 1531-1536.
4. McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med 1997; 126: 307-314.
5. McMillan R. Long-term outcomes after treatment for refractory immune thrombocytopenic purpura. N Engl J Med 2001; 344: 1402-1403.
6. Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R et al. Autologous peripheral blood stem and progenitor (CD34 +) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 1998; 7: 492-494.
7. George JN, Woolf SH, Raskob GE. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88: 3-40.
8. Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1519-1538.
9. Pizzuto J, Ambriz R. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: multicentric trial of the Cooperative Latin American Group on Hemostasis and Thrombosis. Blood 1984; 64: 1179-1183.
10. Bellucci S, Charpak Y, Chastang C, Tobelem G. Low doses v conventional doses of corticoids in immune thrombocytopenic purpura (ITP): results of a randomized clinical trial in 160 children, 223 adults. Blood 1988; 71: 1165-1169.
11. DiFino SM, Lachant NA, Kirshner JJ, Gottlieb AJ. Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med 1980; 69: 430-442.
12. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991; 77: 31-33.
13. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT, Oliva F et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 1995; 98: 436-442.
14. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 2000; 160: 1630-1638.
15. Vianelli N, Valdré L, Fiacchini M, de Vivo A, Gugliotta L, Catani L et al. Long-term follow-up of idiopathic thrombocytopenic purpura in 310 patients. Haematologica 2001; 86: 504-509.
16. Linares M, Cerveró A, Colomina P, Pastor E, Lopez A, Perez A et al. Chronic idiopathic thrombocytopenic purpura in the elderly. Acta Haematol 1995; 93: 80-82.
17. Godeau B, Chevret S, Varet B, Lefrere F, Zini JM, Bassompierre F et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisolone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 2002; 359: 23-29.
18. Portielje JE, Westendorp RG, Kluin-Nelemans HC, Brand A et al. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001; 97: 2549-2554.
19. Heckman KD, Weiner GJ, Davis CS, Strauss RG, Jones MP, Burns CP. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/μL versus 20,000/μL. J Clin Oncol 1997; 15: 1143-1149.
20. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G et al. The Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto: The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 1997; 337: 1870-1875.
21. Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A et al. Safety and cost effectiveness of a 10 × 10(9)/ L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998; 91: 3601-3606.